{"DataElement":{"publicId":"3005293","version":"1","preferredName":"Graft Versus Host Disease Diagnosis Type","preferredDefinition":"Type of Graft vs. Host Disease (GVHD) assessed at the time of participant enrollment on a study.","longName":"GVHD_DX_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2590685","version":"1","preferredName":"Graft Versus Host Disease Diagnosis","preferredDefinition":"information related to the investigation, analysis and recognition of the presence and nature of graft versus host disease, an incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host.","longName":"GVHD_DX","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512808","version":"1","preferredName":"Graft Versus Host Disease","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89816F-5205-32C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27D077C8-B0C1-09D3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2991793","version":"1","preferredName":"Graft Versus Host Disease Diagnosis Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Type; a subdivision of a particular kind of thing.","longName":"GVHD_DX_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Classic cGVHD","valueDescription":"Chronic Graft versus Host Disease (GVHD) without features characteristic of acute GVHD","ValueMeaning":{"publicId":"2991794","version":"1","preferredName":"Chronic Graft versus Host Disease (GVHD) without features characteristic of acute GVHD","longName":"2991794v1.00","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC4B689-DB91-B853-E040-BB89AD4340FF","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"GDEEN","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC4B689-DBAA-B853-E040-BB89AD4340FF","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"Overlap cGVHD","valueDescription":"Features of chronic and acute Graft versus Host Disease (GVHD) appear together","ValueMeaning":{"publicId":"2991795","version":"1","preferredName":"Features of chronic and acute Graft versus Host Disease (GVHD) appear together","longName":"2991795","preferredDefinition":"Features of chronic and acute Graft versus Host Disease (GVHD) appear together","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC4B689-DBB4-B853-E040-BB89AD4340FF","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC4B689-DBCD-B853-E040-BB89AD4340FF","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"Late Acute GVHD","valueDescription":"Features of classic acute Graft versus Host Disease (GVHD) without diagnostic or distinctive manifestations of chronic GVHD occurring beyond 100 days of transplantation or Donor Lymphocyte Infusion (DLI)","ValueMeaning":{"publicId":"2991796","version":"1","preferredName":"Features of classic acute Graft versus Host Disease (GVHD) without diagnostic or distinctive manifestations of chronic GVHD occurring beyond 100 days of transplantation or Donor Lymphocyte Infusion (DLI)","longName":"2991796","preferredDefinition":"Features of classic acute Graft versus Host Disease (GVHD) without diagnostic or distinctive manifestations of chronic GVHD occurring beyond 100 days of transplantation or Donor Lymphocyte Infusion (DLI)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC4B689-DBD7-B853-E040-BB89AD4340FF","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC4B689-DBF0-B853-E040-BB89AD4340FF","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E185541-7C81-E19A-E050-BB89AD433B15","beginDate":"2016-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"Acute GVHD","valueDescription":"Acute Graft Versus Host Disease","ValueMeaning":{"publicId":"4722619","version":"1","preferredName":"Acute Graft Versus Host Disease","longName":"4722619v1.00","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A8282-65AC-8ABC-E050-BB89AD43579F","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-30","changeDescription":null,"administrativeNotes":"2023.10.30 Alt VM added per ticket request CADSR0003010. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59127196-8B43-1BDE-E053-F662850A86CB","beginDate":"2017-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2991792","version":"1","preferredName":"Graft Versus Host Disease Diagnosis Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Type; a subdivision of a particular kind of thing.","longName":"C3063:C15220:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC4B689-DB6D-B853-E040-BB89AD4340FF","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC4B689-DB7E-B853-E040-BB89AD4340FF","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-22","modifiedBy":"COOPERM","dateModified":"2017-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"GVHD Type","type":"Preferred Question Text","description":"GVHD Type","url":null,"context":"CCR"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Is GVHD acute or chronic?","url":null,"context":"Theradex"},{"name":"Type of GvHD:","type":"Alternate Question Text","description":"Type of GvHD:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAAAB23-82AC-3381-E040-BB89AD435A9F","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"GDEEN","dateModified":"2023-04-17","changeDescription":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}